Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-048255
Filing Date
2023-09-05
Accepted
2023-09-05 20:10:08
Documents
1
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5702
  Complete submission text file 0001209191-23-048255.txt   7260
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3721 VALLEY CENTRE DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Dube Eric M (Reporting) CIK: 0001763494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 231237534